Michael Barbella, Managing Editor02.01.24
Microbot Medical Inc., the developer of the LIBERTY Robotic Surgical System, the first single-use endovascular robotic system, has been granted a registered trademark from the U.S. Patent and Trademark Office.
The trademark “One & Done®” was given to the feature of the LIBERTY System, which is being developed to integrate guidewires, microcatheters and other instruments required for complete endovascular procedures using the device. With this trademark, the company continues to expand its proprietary assets, including numerous approved and pending patents worldwide, and differentiate its product’s capabilities.
The LIBERTY Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures today by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The company believes the LIBERTY Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.
Microbot Medical Inc. is a pre-clinical medical device company specializing in micro-robotic technologies that help improve clinical outcomes for patients and increase accessibility through the body's natural and artificial lumens.
The trademark “One & Done®” was given to the feature of the LIBERTY System, which is being developed to integrate guidewires, microcatheters and other instruments required for complete endovascular procedures using the device. With this trademark, the company continues to expand its proprietary assets, including numerous approved and pending patents worldwide, and differentiate its product’s capabilities.
The LIBERTY Robotic Surgical System aims to improve the way surgical robotics are being used in endovascular procedures today by eliminating the need for large, cumbersome, and expensive capital equipment, while reducing radiation exposure and physician strain. The company believes the LIBERTY Robotic Surgical System’s remote operation has the potential to be the first system to democratize endovascular interventional procedures.
Microbot Medical Inc. is a pre-clinical medical device company specializing in micro-robotic technologies that help improve clinical outcomes for patients and increase accessibility through the body's natural and artificial lumens.